Tumor-educated Gr1+CD11b+cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticityJOURNAL OF CLINICAL INVESTIGATIONIF13.62024-01-183OAAI
Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activationSCIENCE TRANSLATIONAL MEDICINEIF14.62022-09-0718PRE
Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR AxisCANCER RESEARCHIF16.62021-02-0124OA
Targeting the Extra-Cellular Matrix-Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin InhibitorsFRONTIERS IN ONCOLOGYIF3.32020-07-2223OAAI
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancerONCOGENEIF7.32018-12-1384OAAI
Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progressionINTERNATIONAL JOURNAL OF CANCERIF4.72014-03-0414OAAI
Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor suppressorONCOGENEIF7.32013-11-1120OAAI
Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after RadiotherapyCLINICAL CANCER RESEARCHIF10.22012-08-1462OA
New insights into the mechanisms of organ-specific breast cancer metastasisSEMINARS IN CANCER BIOLOGYIF15.72012-06-01143OAAI
Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic ProgenitorsCANCER RESEARCHIF16.62011-05-3134OAAI
Mechanisms of Hyperforin as an anti-angiogenic angioprevention agentEUROPEAN JOURNAL OF CANCERIF7.12009-05-0135PREAI
Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key targetJOURNAL OF TRANSLATIONAL MEDICINEIF7.52009-01-1444OAAI
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agentMOLECULAR CANCER THERAPEUTICSIF5.52007-12-1881PREAI
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosisJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82007-05-0153PREAI
Inhibition of anti-angiogenesis cardiovascular events and chemotherapy cardiotoxicity by angioprevention agentsTHROMBOSIS RESEARCHIF3.42007-01-010PREAI